FDA approves at-home flu vaccine
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s FluMist was approved Friday by regulators for household administration in patients ages 2 to 49. The spray, which has been available via a doctor's visit since 2003, is roughly as as effective as injected vaccines.